ATE357916T1 - Tiagabine zur behandlung von diabetischer neuropathie - Google Patents

Tiagabine zur behandlung von diabetischer neuropathie

Info

Publication number
ATE357916T1
ATE357916T1 AT01986237T AT01986237T ATE357916T1 AT E357916 T1 ATE357916 T1 AT E357916T1 AT 01986237 T AT01986237 T AT 01986237T AT 01986237 T AT01986237 T AT 01986237T AT E357916 T1 ATE357916 T1 AT E357916T1
Authority
AT
Austria
Prior art keywords
diabetic neuropathy
tiagabine
treatment
migraine
butenyl
Prior art date
Application number
AT01986237T
Other languages
English (en)
Inventor
Stephen D Collins
Roger L Deaton
William J Giardina
Adrienne L Gilbert
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of ATE357916T1 publication Critical patent/ATE357916T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
AT01986237T 2000-10-20 2001-10-19 Tiagabine zur behandlung von diabetischer neuropathie ATE357916T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US69336100A 2000-10-20 2000-10-20

Publications (1)

Publication Number Publication Date
ATE357916T1 true ATE357916T1 (de) 2007-04-15

Family

ID=24784340

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01986237T ATE357916T1 (de) 2000-10-20 2001-10-19 Tiagabine zur behandlung von diabetischer neuropathie

Country Status (8)

Country Link
EP (1) EP1331933B1 (de)
JP (1) JP4387102B2 (de)
AT (1) ATE357916T1 (de)
CA (1) CA2421042C (de)
DE (1) DE60127571T2 (de)
ES (1) ES2284711T3 (de)
MX (1) MXPA03003310A (de)
WO (1) WO2002038144A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1583562T1 (sl) 2003-01-06 2011-10-28 Angiochem Inc AngioPep-1, sorodne spojine in njihove uporabe
US9365634B2 (en) 2007-05-29 2016-06-14 Angiochem Inc. Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
JP2012505637A (ja) 2008-10-15 2012-03-08 アンジオケム，インコーポレーテッド Ｇｌｐ−１アゴニストのコンジュゲート及びその使用
CA2989400A1 (en) 2015-06-15 2016-12-22 Angiochem Inc. Ang1005 for the treatment of leptomeningeal carcinomatosis

Also Published As

Publication number Publication date
DE60127571T2 (de) 2008-01-24
EP1331933A2 (de) 2003-08-06
DE60127571D1 (de) 2007-05-10
ES2284711T3 (es) 2007-11-16
MXPA03003310A (es) 2003-09-10
CA2421042A1 (en) 2002-05-16
WO2002038144A2 (en) 2002-05-16
WO2002038144A8 (en) 2002-07-11
JP2004513145A (ja) 2004-04-30
EP1331933B1 (de) 2007-03-28
CA2421042C (en) 2011-07-05
JP4387102B2 (ja) 2009-12-16

Similar Documents

Publication Publication Date Title
DE69924641D1 (de) Behandlung von asthma anhand von mek-inhibitoren
ATE450269T1 (de) Peptid pyyä3-36ü zur behandlung von stoffwechselkrankheiten
DE69905938T2 (de) Kombination von duloxetin mit nichtsteroid-entzündungshemmern für die behandlung von schmerz
ATE207352T1 (de) Nicht-allosterische gaba a agonisten zur behandlung von schlafstörungen
NO20060416L (no) Ny anvendelse I
DE60215787D1 (de) Behandlung von typ ii diabetes mit dipeptidyl-peptidase-iv-hemmern
TR200200205T2 (tr) MEK inhibitörleri kullanılarak kronik ağrının tedavi edilmesi
BR0008958A (pt) Inibidores de reabsorção de monoamina para otratamento de distúrbios do snc
DE69833971D1 (de) Verfahren zur behandlung von alzheimerschen krankheit
DK1301201T3 (da) Behandling af glycogenosis type II
ATE315390T1 (de) Zyklische polyamine zur behandlung der thrombozytopenie
NO20005668L (no) Forbindelser med veksthormonfrigjörende egenskaper
ATE323693T1 (de) Calciumkanalantagonisten vom n-typ zur behandlung von schmerzen
ES2119094T3 (es) Inhibicion de la hemorragia uterina disfuncional.
ATE516027T1 (de) Orazamid orotat zur vorbeugung von leberschäden
RS50148B (sr) Upotreba docetaksela za lečenje hepatoćelijskog karcinoma
DE59914712D1 (de) Verwendung von inhibitoren des kqt1-kanals zur herstellung eines medikaments zur behandlung von krankheiten, die durch helminthen und ektoparasiten hervorgerufen werden
ATE357916T1 (de) Tiagabine zur behandlung von diabetischer neuropathie
DE69808475T2 (de) Aminosäurederivate zur behandlung von schlaganfall
ATE321045T1 (de) Methoden und zusammensetzungen zur behandlung von schmerzen
DE60015098D1 (de) 3-cyclopropylmethoxy-4-difluormethoxy-n-(3,5-dichlor-pyrid-4-yl)-benzamid zur behandlung von multipler sklerose
SE0301885D0 (sv) New use IV
SE0301884D0 (sv) New use III
HUP9904035A2 (hu) Módosított kristály formájú R(-)-N-(4,4-di(3-metil-tien-2-il)-but-3-enil)-nipekotinsav-hidroklorid
ATE536874T1 (de) Dreifache monoamin-wiederaufnahmehemmer zur behandlung von chronischen schmerzen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties